6051 results for "canc*"
in 39.72 milliseconds.
-
AGECAN - DAC (Interespecies conservation of brain specific DNA methylation in aging and cancer)
Dac EGAC00001001840 -
PBL Cancer Data Committee
Dac EGAC00001001870 -
Peter MacCallum Cancer Centre Research Data Access Committee
Dac EGAC00001001906 -
Division of Cellular Signaling National Cancer Center Research Institute
Dac EGAC00001001909 -
DAC Panel Evaluation
Dac EGAC00001001914 -
Data access committee for lung cancer
Dac EGAC00001001942 -
4C Ovarian Cancer Data Access Committee
Dac EGAC00001001953 -
Singapore Gastric Cancer Consortium Data Access Committee
Dac EGAC00001001955 -
4C Endometrial Cancer Data Access Committee
Dac EGAC00001001956 -
HER2-negative primary breast cancers WES
Dac EGAC00001001973 -
Breast Cancer Single-Cell Data Access Committee
Dac EGAC00001001974 -
BCRC-ICGS (Bladder Cancer Research Centre, Institute of Cancer and Genomic Sciences, Univ. of Birmingham) Data Access Committee
Dac EGAC00001001982 -
Peter MacCallum Cancer Centre Research Data Access Committee
Dac EGAC00001001988 -
Whole Exome Sequencing of Mixed Histology Lung Cancer at MDACC
Dac EGAC00001002034 -
Division of Molecular Oncology, National Cancer Center Research Institute Data Access Committee
Dac EGAC00001002007 -
bladder cancer data access commitee
Dac EGAC00001002016 -
Data Access Commitee of Nanjing Medical University Affiliated Jiangsu Cancer Hospital
Dac EGAC00001002086 -
Charbonneau Cancer Institute DAC
Dac EGAC00001002096 -
Breast Cancer Single-Cell Data Access Committee
Dac EGAC00001002160 -
AA/UTUC Cancer Data Access Commitee
Dac EGAC00001002162 -
MRC Institute of Genetics and Cancer Data Access Committee
Dac EGAC00001002163 -
University of Calgary Charbonneau Cancer Institute
Dac EGAC00001002170 -
The data access committee for Detection and characterization of lung cancer using cell-free DNA fragmentomes
Dac EGAC00001002184 -
TCRseq in cancers DAC
Dac EGAC00001002235 -
Cancer Proteomics Mass Spectrometry group
Dac EGAC00001002236 -
CRMY team data access committee
Dac EGAC00001002249 -
The MITIMM Cancer Data Access Committee
Dac EGAC00001002268 -
Expression-Based Subtypes Define Pathologic Response to Neoadjuvant Immune-Checkpoint Inhibitors in Muscle-Invasive Bladder Cancer
Dac EGAC00001002276 -
Data access committee breast cancer whole genome sequencing HRD
Dac EGAC00001002286 -
Breast Cancer Single-Cell Data Access Committee
Dac EGAC00001002291 -
Genomics to select patients with metastatic breast cancer for targeted therapy DAC
Dac EGAC00001002293 -
RNA-sequencing of tumors from 45 patients with recurrent or metastatic gastric cancer treated with immune checkpoint inhibitors
Dac EGAC00001002295 -
EPICC: Evolutionary Predictions in Colorectal Cancer
Dac EGAC00001002299 -
OV cancer cell lines DAC
Dac EGAC00001002307 -
Division of Molecular Oncology, National Cancer Center Research Institute Data Access Committee
Dac EGAC00001002331 -
MDACC Breast Cancer MoonShot Data Access Committee
Dac EGAC00001002362 -
Lung cancer cfDNA dataset DAC
Dac EGAC00001002387 -
Lung cancer cfDNA dataset DAC
Dac EGAC00001002388 -
Somatic pathogenic variants in the normal mammary gland of sporadic breast cancer patients.
Dac EGAC00001002391 -
Leeds institute of Medical Research Bladder Cancer Research Group
Dac EGAC00001002397 -
Cancer Clinical Research Trust DAC for the 23 WES samples of melanoma subtypes
Dac EGAC00001002402 -
Cancer Team Data Access Committee
Dac EGAC00001002449 -
University of Melbourne Centre for Cancer Research (UMCCR) Data Access Committee
Dac EGAC00001002442 -
Netherlands Cancer Institute - Breast Cancer Neoadjuvant chemotherapy biomarker studies
Dac EGAC00001002452 -
Cancer Sequencing Data Access Committee
Dac EGAC00001002457 -
Cancer Core Europe Data Access Commitee
Dac EGAC00001002460 -
Data Access Committee for the study "Somatic chronology of treatment-resistant prostate cancer via deep whole-genome ctDNA sequencing"
Dac EGAC00001002479 -
Whole-exome sequencing of 47 microsatellites stable Early-onset sporadic rectal cancer (EOSRC) tumors and corresponding normal samples.
Dac EGAC00001002502 -
Laboratory of Applied Cancer Genomics team
Dac EGAC00001002508 -
Peter MacCallum Cancer Centre Research Data Access Committee
Dac EGAC00001002510 -
DAC of The polarity and specificity of antiviral T lymphocyte responses determine susceptibility to SARS-CoV-2 infection in cancer patients and healthy individuals
Dac EGAC00001002517 -
Laboratory of Applied Cancer Genomics team
Dac EGAC00001002520 -
Laboratory of Applied Cancer Genomics team
Dac EGAC00001002526 -
Laboratory of Applied Cancer Genomics team
Dac EGAC00001002535 -
Laboratory of Applied Cancer Genomics team
Dac EGAC00001002541 -
Laboratory of Applied Cancer Genomics team
Dac EGAC00001002546 -
Laboratory of Applied Cancer Genomics team
Dac EGAC00001002554 -
GIS - NCCS Pancreatic Cancer DAC
Dac EGAC00001002565 -
Laboratory of Applied Cancer Genomics team
Dac EGAC00001002580 -
Prostate Cancer Sample Data Access Commitee
Dac EGAC00001002586 -
Laboratory of Applied Cancer Genomics team
Dac EGAC00001002587 -
EPICC: Evolutionary Predictions in Colorectal Cancer
Dac EGAC00001002592 -
Prostate Cancer Sample Data Access Commitee
Dac EGAC00001002593 -
Lung cancer cfDNA dataset DAC
Dac EGAC00001002608 -
Netherlands Cancer Institute (NKI) - Wilbert Zwart Group
Dac EGAC00001002618 -
DAC for Clonal somatic copy number altered driver events inform drug sensitivity in high-grade serous ovarian cancer
Dac EGAC00001002644 -
UCL cancer institute data access commitee
Dac EGAC00001002659 -
Salivary gland cancer TSO500 data team
Dac EGAC00001002668 -
Genomics characterization of BRAF-V600E colorectal cancer patients treated with anti-BRAF/EGFR
Dac EGAC00001002669 -
Breast Cancer Single-Cell Data Access Committee
Dac EGAC00001002691 -
Computational Cancer Genomics and Tumor Evolution Group
Dac EGAC00001002722 -
MSKCC Colorectal Cancer Plasma WGS Data Access Comittee
Dac EGAC00001002741 -
Netherlands Cancer Institute (NKI) - Jos Jonkers Group
Dac EGAC00001002749 -
Southern African Prostate Cancer Study (SAPCS) Data Access Committee
Dac EGAC00001002768 -
Garvan/St Vincent’s Prostate Cancer Tissue and Data Access Committee
Dac EGAC00001002769 -
Breast cancer bone metastases
Dac EGAC00001002771 -
Breast cancer bone metastases
Dac EGAC00001002772 -
Netherlands Cancer Institute (NKI) - Wilbert Zwart Group
Dac EGAC00001002782 -
DAC Synergie Lyon Cancer
Dac EGAC00001002795 -
Colorectal cancer samples
Dac EGAC00001002808 -
RNAseq analysis on metastatic Colorectal Cancer xenografts samples
Dac EGAC00001002809 -
Peter MacCallum Cancer Centre Research Data Access Committee
Dac EGAC00001002829 -
Netherlands Cancer Institute (NKI) - Jos Jonkers Group
Dac EGAC00001002848 -
Treatment-mediated selection of lethal prostate cancer clones defined by copy number architectures
Dac EGAC00001002865 -
Cancers of Unknown Primary
Dac EGAC00001002878 -
Cancer Team Data Access Committee
Dac EGAC00001002891 -
Pancreatic cancer PDOs/CAFs DAC
Dac EGAC00001002897 -
Pan Cancer Plasma cfRNA DAC
Dac EGAC00001002956 -
Peter MacCallum Cancer Centre Research Data Access Committee
Dac EGAC00001002975 -
INSERM U944 Team Genome and Cancer
Dac EGAC00001002976 -
DAC Molecular heterogeneity and commonalities in pancreatic cancer precursors with gastric and intestinal phenotype
Dac EGAC00001002978 -
Cancer Team Data Access Committee
Dac EGAC00001002982 -
NPY methylated ctDNA is a promising biomarker for treatment response monitoring in metastatic colorectal cancer
Dac EGAC00001003001 -
Leeds Cancer Genomics
Dac EGAC00001003010 -
Ovarian Cancer Data Access Committee
Dac EGAC00001003014 -
Breast cancer bone metastases
Dac EGAC00001003035 -
Hoag Family Cancer Institute Carcinoid Multiomic Study Data Access Committee
Dac EGAC00001003084 -
DAC - Pediatric Solid Cancer
Dac EGAC00001003088 -
Cancer Genomics of the Kidney - Targeted Sequencing
Dac EGAC00001003091 -
RNAseq analysis on metastatic Colorectal Cancer xenografts samples
Dac EGAC00001003125